Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of Mediterranean visceral leishmaniasis.

Literature DB >> 7743590

Treatment of Mediterranean visceral leishmaniasis.

Abstract

Up-to-date information is given on the epidemiological situation of zoonotic visceral leishmaniasis (ZVL) in nine Mediterranean countries, and on drug regimens adopted in the management of ZVL patients in each country. Results of experimental and clinical trials on the efficacy and tolerability of liposomal amphotericin B in laboratory animals and in patients with ZVL are presented, as well as conclusions and recommendations on drug regimens to be used in the treatment of ZVL.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1995 PMID： 7743590 PMCID： PMC2486749

Source DB: PubMed Journal: Bull World Health Organ ISSN： 0042-9686 Impact factor: 9.408

6 in total

1. Prevalence of Leishmania infection among AIDS patients.

Authors: J Alvar; B Gutiérrez-Solar; R Molina; R López-Velez; A Garcia-Camacho; P Martinez; F Laguna; E Cercenado; A Galmes
Journal: Lancet Date: 1992-06-06 Impact factor: 79.321

2. Practical progress and new drugs for changing patterns of leishmaniasis.

Authors: P L Olliaro; A D Bryceson
Journal: Parasitol Today Date: 1993-09

3. Liposomal amphotericin B in drug-resistant visceral leishmaniasis.

Authors: R N Davidson; S L Croft; A Scott; M Maini; A H Moody; A D Bryceson
Journal: Lancet Date: 1991-05-04 Impact factor: 79.321

4. The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing.

Authors: L Gradoni; R Pizzuti; L di Martino; M Gramiccia; R Pempinello; G B Gaeta; M Ferrara; S Scotti; S Altieri
Journal: Epidemiol Infect Date: 1993-10 Impact factor: 2.451

5. Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis.

Authors: L di Martino; F Raimondi; S Scotti; R N Davidson; L Gradoni; R Giacchino
Journal: Trans R Soc Trop Med Hyg Date: 1993 Jul-Aug Impact factor: 2.184

6. Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis.

Authors: R Giacchino; G Giambartolomei; L Tasso; A Timitilli; E Castagnola; M Brisigotti; C Micalizzi
Journal: Trans R Soc Trop Med Hyg Date: 1993 May-Jun Impact factor: 2.184

6 in total

18 in total

Review 1. Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors: H W Murray
Journal: Antimicrob Agents Chemother Date: 2001-08 Impact factor: 5.191

2. Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model.

Authors: M Paul; R Durand; H Fessi; D Rivollet; R Houin; A Astier; M Deniau
Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191

3. Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B.

Authors: Maryam Iman; Zhaohua Huang; Seyedeh Hoda Alavizadeh; Francis C Szoka; Mahmoud R Jaafari
Journal: Antimicrob Agents Chemother Date: 2017-08-24 Impact factor: 5.191

4. Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Authors: J P Gangneux; M Dullin; A Sulahian; Y J Garin; F Derouin
Journal: Antimicrob Agents Chemother Date: 1999-01 Impact factor: 5.191

5. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors: V Yardley; S L Croft
Journal: Antimicrob Agents Chemother Date: 1997-04 Impact factor: 5.191

6. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Authors: J P Gangneux; A Sulahian; Y J Garin; R Farinotti; F Derouin
Journal: Antimicrob Agents Chemother Date: 1996-05 Impact factor: 5.191

7. Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network.

Authors: T Weitzel; N Mühlberger; T Jelinek; M Schunk; S Ehrhardt; C Bogdan; K Arasteh; T Schneider; W V Kern; G Fätkenheuer; G Boecken; T Zoller; M Probst; M Peters; T Weinke; S Gfrörer; H Klinker; M-L Holthoff-Stich
Journal: Eur J Clin Microbiol Infect Dis Date: 2005-07 Impact factor: 3.267